Ovid Therapeutics (OVID) EPS (Basic) Growth (5y) (2021 - 2026)
Ovid Therapeutics (OVID) EPS (Basic) Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.30% |
| Dec 31, 2025 | 18.13% |
| Sep 30, 2025 | 42.85% |
| Jun 30, 2025 | 59.07% |
| Mar 31, 2025 | 57.83% |
| Dec 31, 2024 | 16.27% |
| Sep 30, 2024 | 52.89% |
| Jun 30, 2024 | 15.07% |
| Mar 31, 2024 | 55.48% |
| Dec 31, 2023 | 16.15% |
| Sep 30, 2023 | 21.25% |
| Jun 30, 2023 | 19.65% |
| Mar 31, 2023 | 18.77% |
| Dec 31, 2022 | 22.02% |
| Sep 30, 2022 | 14.88% |
| Jun 30, 2022 | 18.20% |
| Mar 31, 2022 | 41.97% |
| Dec 31, 2021 | 12.90% |
| Sep 30, 2021 | 22.20% |
| Jun 30, 2021 | 15.72% |